Fundamental Analysis of CENTOGENE NV(NASDAQ:CNTG) stock

Fundamental Rating

Overall CNTG gets a fundamental rating of 1 out of 10. We evaluated CNTG against 111 industry peers in the Health Care Providers & Services industry. CNTG may be in some trouble as it scores bad on both profitability and health. CNTG is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CNTG has reported negative net income.

In the past year CNTG has reported a negative cash flow from operations.

CNTG had negative earnings in each of the past 5 years.

CNTG had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -46.05%, CNTG is not doing good in the industry: 85.34% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-46.05%
ROE	N/A
ROIC	N/A

ROA(3y)-43.71%

ROA(5y)-32.71%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 36.46%, CNTG is doing good in the industry, outperforming 63.79% of the companies in the same industry.

In the last couple of years the Gross Margin of CNTG has declined.

The Profit Margin and Operating Margin are not available for CNTG so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	36.46%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y21.22%

GM growth 5Y-6.4%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CNTG does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, CNTG has more shares outstanding

The number of shares outstanding for CNTG has been increased compared to 5 years ago.

Compared to 1 year ago, CNTG has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -1.03, we must say that CNTG is in the distress zone and has some risk of bankruptcy.

CNTG has a worse Altman-Z score (-1.03) than 81.03% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-1.03

ROIC/WACCN/A

WACC7.5%

2.3 Liquidity

CNTG has a Current Ratio of 1.02. This is a normal value and indicates that CNTG is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of CNTG (1.02) is worse than 68.10% of its industry peers.

CNTG has a Quick Ratio of 1.02. This is a bad value and indicates that CNTG is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.96, CNTG is doing worse than 62.07% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.02
Quick Ratio	0.96

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CNTG shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.92%.

CNTG shows a small growth in Revenue. In the last year, the Revenue has grown by 2.25%.

The Revenue has been growing slightly by 3.70% on average over the past years.

EPS 1Y (TTM)-6.92%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-6.92%

Revenue 1Y (TTM)2.25%

Revenue growth 3Y8.07%

Revenue growth 5Y3.7%

Sales Q2Q%254.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y39.38%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year22.37%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNTG. In the last year negative earnings were reported.

Also next year CNTG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CNTG!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CENTOGENE NV

NASDAQ:CNTG (8/7/2024, 8:06:53 PM)

After market: 0.351 +0.03 (+8%)

0.325

-0.02 (-6.23%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap8.97M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-46.05%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	36.46%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.63

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.02
Quick Ratio	0.96
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-6.92%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y39.38%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)2.25%

Revenue growth 3Y8.07%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

CENTOGENE NV (CNTG)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens